Positive lymph node status is not a reliable indicator of the need for adjunctive chemotherapy, and sentinel node biopsy may not be helpful in older women with certain low-risk breast cancers, according to a study presented ...
Apr 13, 2022
0
2
Susana Garcia-Recio, Ph.D., a research associate in the lab of Charles M. Perou, Ph.D., at UNC Lineberger Comprehensive Cancer Center, will present findings that identified molecular features responsible for the development ...
Apr 11, 2022
0
3
Liquid biopsy performed on serum samples taken from breast cancer patients can provide increasingly accurate information on cancer progression and enable earlier detection of cancer recurrence, a new study from the University ...
Mar 29, 2022
0
8
From March to September 2020, breast biopsies and detected cancers at U.S. Breast Cancer Surveillance Consortium facilities dropped sharply, compared with the same span a year earlier: Biopsies declined by 23% and detected ...
Nov 1, 2021
0
28
A novel laboratory test in development by researchers at the Johns Hopkins Kimmel Cancer Center may be used to help quickly distinguish breast cancer from benign disease. The breast cancer detection assay (BCDA) examines ...
Aug 30, 2021
0
6
Oncologists faced with treating older women with breast cancer often must decide if the treatment may be more detrimental than the cancer. A study published today in JAMA Network Open by researchers at UPMC Hillman Cancer ...
Apr 15, 2021
0
13
Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of recovery. Magnetic resonance imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue. ...
Mar 1, 2021
0
10
A team from the Gamma and Neutron Spectroscopy Group of the Corpuscular Physics Institute (IFIC) has patented a new device for real-time guided biopsies, with direct application in any type of cancer that requires a biopsy ...
Jan 28, 2021
0
1
Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study.
Oct 8, 2020
0
12
A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.
Sep 11, 2020
0
4
